Aerovate Therapeutics, Inc. Contracts & Agreements

36 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Employment Agreement between the Registrant and Ralph Niven, to be in effect upon the closing of this offering
Employment Agreements
Aerovate Therapeutics, Inc.
Biotechnology
CA
2021
Cell Line License Agreement, effective October 22, 2024, by and between WuXi Biologics Ireland Limited and Jade Biosciences, Inc
License Agreements
Aerovate Therapeutics, Inc.
2024
Jade Biosciences, Inc. Amended and Restated 2024 Equity Incentive Plan and the Form of Stock Option Agreement thereunder
Bonus & Incentive Agreements
Aerovate Therapeutics, Inc.
2024
Form of Restricted Stock Purchase Agreement
Stock Agreements
Aerovate Therapeutics, Inc.
2024
Offer Letter between Jade Biosciences, Inc. and Tom Frohlich, dated as of August 20, 2024
Aerovate Therapeutics, Inc.
2024
Offer Letter between Jade Biosciences, Inc. and Jonathan Quick, dated as of August 29, 2024
Aerovate Therapeutics, Inc.
2024
Offer Letter between Jade Biosciences, Inc. and Andrew King, dated as of July 31, 2024
Aerovate Therapeutics, Inc.
2024
Offer Letter between Jade Biosciences, Inc. and Hetal Kocinsky, dated as of September 3, 2024
Aerovate Therapeutics, Inc.
2024
Offer Letter between Jade Biosciences, Inc. and Elizabeth Balta, dated as of October 21, 2024
Aerovate Therapeutics, Inc.
2024
Antibody Discovery and Option agreement, dated July 24, 2024, by and between Paragon Therapeutics, Inc., Parade Biosciences Holding, LLC and Jade Biosciences, Inc
Aerovate Therapeutics, Inc.
2024
Amendment No. 1 to Antibody Discovery and Option Agreement, dated as of September 27, 2024
Aerovate Therapeutics, Inc.
2024
Biologics Master Services Agreement, effective July 10, 2024, by and between WuXi Biologics (Hong Kong) Limited) and Jade Biosciences, Inc
Services Agreements
Aerovate Therapeutics, Inc.
2024
APRIL License Agreement, dated October 30, 2024, by and between Paragon Therapeutics, Inc. and Jade Biosciences, Inc
License Agreements
Aerovate Therapeutics, Inc.
2024
Separation and Release Agreement, by and between the Registrant and Timothy Pigot, dated August 15, 2024
Separation Agreements
Aerovate Therapeutics, Inc.
2024
Lease Amendment, dated January 2, 2024, by and between the Registrant and PDM 930 Unit, LLC
Lease Agreements
Aerovate Therapeutics, Inc.
2024
Lease, Amendment, dated January 2, 2024, by and between the Registrant and PDM 930 Unit, LLC
Lease Agreements
Aerovate Therapeutics, Inc.
2024
Compensation Recovery Policy
Compensation Agreements
Aerovate Therapeutics, Inc.
2023
ATM Equity OfferingSM Sales Agreement, dated as of April 5, 2023, by and between Aerovate Therapeutics, Inc. and BofA Securities, Inc
Sales Agreements
Aerovate Therapeutics, Inc.
2023
Lease, dated April 26, 2022, by and between the Registrant and Hudson Metro Center, LLC
Lease Agreements
Aerovate Therapeutics, Inc.
Biotechnology
CA
2022
Description of Securities
Aerovate Therapeutics, Inc.
2022
Lease, dated August 6, 2021, by and between the Registrant and PDM 930 Unit, LLC
Lease Agreements
Aerovate Therapeutics, Inc.
Biotechnology
MA
2021
Employment Agreement between the Registrant and Hunter Gillies, to be in effect upon the closing of this offering
Employment Agreements
Aerovate Therapeutics, Inc.
Biotechnology
CA
2021
Employment Agreement between the Registrant and Benjamin T. Dake, to be in effect upon the closing of this offering
Employment Agreements
Aerovate Therapeutics, Inc.
2021
Form of Underwriting Agreement
Underwriting Agreements
Aerovate Therapeutics, Inc.
2021
Form of Indemnification Agreement between the Registrant and each of its directors and executive officers
Indemnification Agreements
Aerovate Therapeutics, Inc.
Biotechnology
DE
2021
Form of Specimen Common Stock Certificate
Stock Agreements
Aerovate Therapeutics, Inc.
Biotechnology
2021
2021 Stock Option and Incentive Plan, and form of award agreements thereunder
Bonus & Incentive Agreements
Aerovate Therapeutics, Inc.
Biotechnology
DE
2021
2021 Employee Stock Purchase Plan
Stock Agreements
Aerovate Therapeutics, Inc.
Biotechnology
DE
2021
Non-Employee Director Compensation Policy
Compensation Agreements
Aerovate Therapeutics, Inc.
2021
Form of Amended and Restated Employment Agreement
Employment Agreements
Aerovate Therapeutics, Inc.
Biotechnology
CA
2021
Senior Executive Cash Incentive Bonus Plan
Bonus & Incentive Agreements
Aerovate Therapeutics, Inc.
2021
Investors Rights Agreement among the Registrant and certain of its stockholders, dated August 5, 2020
Investor Rights Agreements
Aerovate Therapeutics, Inc.
Biotechnology
DE
2021
Offer Letter between the Registrant and Ralph Niven, dated April 26, 2020
Aerovate Therapeutics, Inc.
2021
Offer Letter between the Registrant and Hunter Gillies, dated April 27, 2020
Aerovate Therapeutics, Inc.
2021
Offer Letter between the Registrant and Benjamin T. Dake, dated November 4, 2019
Aerovate Therapeutics, Inc.
Biotechnology
MA
2021
2018 Equity Incentive Plan, and form of award agreements thereunder
Bonus & Incentive Agreements
Aerovate Therapeutics, Inc.
Biotechnology
DE
2021